Evidence map›Paper›PMID 22791818›Full record

ArticleCarcinogenesis2012

Rats deficient for p53 are susceptible to spontaneous and carcinogen-induced tumorigenesis.

He-Xin Yan, Hong-Ping Wu, Charles Ashton, Chang Tong, Qi-Long Ying

Abstract read
In one paragraph

Article in Carcinogenesis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Rat Models of Breast Cancer.Advances in experimental medicine and biology · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Mouse Homolog of the HumanCancer research · 2018
    Article
  10. From engineering to editing the rat genome.Mammalian genome : official journal of the International Mammalian Genome Society · 2017
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

He-Xin YanDepartment of Cell and Neurobiology, University of Southern California, Los Angeles, CA 90033, USA.
Hong-Ping Wu
Charles Ashton
Chang Tong
Qi-Long Ying

Funding

NON-PARENCHYMAL LIVER CELL CORER24AA012885 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TSUKAMOTO, HIDEKAZU · 2001 to 2025
$8.1M
DERIVATION, PROPAGATION AND GENETIC MODIFICATION OF RAT EMBRYONIC STEM CELLSR01OD010926 · OD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YING, QILONG · 2012 to 2014
$1.2M
NIAAA NIH HHS R24 AA012885NIH HHS R01 OD010926NIH HHS R01OD010926
6 · The paper itself

Abstract

The p53 tumor suppressor gene is highly mutated in human cancers. Individuals who inherit one p53 mutant allele are susceptible to a wide range of tumor types, including breast cancer and sarcoma. We recently generated p53 knockout rats through gene targeting in embryonic stem cells. Here we show that rats homozygous for the null allele are prone to early onset spontaneous sarcomas and lymphoma with high incidence of metastases. Heterozygous rats are also highly predisposed to cancer, but with a delayed onset and a wider spectrum of tumor types compared with homozygotes. Importantly, up to 20% of female heterozygotes developed breast cancer and about 70% of the tumors were positive for estrogen receptor. Exposing p53-deficient rats to a low dose of the carcinogen diethylnitrosamine dramatically decreased the latency for sarcoma development and survival time compared with equivalently treated wild-type rats. These unique features make this knockout line a valuable model for investigating human malignancy and in vivo carcinogenicity of chemicals and therapeutic compounds.

Indexed as

Gene Knockout TechniquesGenes, p53Models, AnimalAllelesAnimalsBreast NeoplasmsCell Transformation, NeoplasticFemaleHeterozygoteHomozygoteLymphomaQuinolinesRatsSarcomaquinaldofurQuinolines

Identifiers

PMID22791818
PMCPMC3499043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.